Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:13 pm Sale | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 2,457,348 4.400% | -1,001,297 (-28.95%) | Filing |
| 2024-11-14 5:45 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 3,458,645 6.100% | 232,839 (+7.22%) | Filing |
| 2024-01-02 4:16 pm Purchase | 2023-12-21 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III, L.P. | 3,225,806 8.900% | 3,225,806 (New Position) | Filing |